HDL dysfunction in diabetes: causes and possible treatments

Area of Science:

• Cardiovascular Science
• Metabolic Disease Research
• Lipid Metabolism Studies

Background:

• High-density lipoprotein (HDL) possesses antiatherogenic properties, including cholesterol efflux and reverse cholesterol transport.
• HDL function can be impaired in pathophysiological states like obesity and inflammation, increasing cardiovascular disease (CVD) risk.
• Diabetes mellitus is linked to HDL dysfunction and accelerated atherosclerosis due to structural modifications impacting HDL function.

Purpose of the Study:

• To review structural modifications of HDL in diabetes mellitus.
• To elucidate how these modifications lead to HDL dysfunction.
• To briefly discuss potential therapeutic strategies for HDL dysfunction in diabetes.

Main Methods:

• Literature review of studies on HDL structure and function in diabetes mellitus.
• Analysis of pathophysiological states affecting HDL.
• Summary of current and potential treatments for HDL dysfunction.

Main Results:

• Diabetes mellitus induces significant structural changes in HDL particles.
• These structural alterations result in impaired HDL functions, contributing to atherosclerosis.
• HDL dysfunction in diabetes is associated with increased cardiovascular risk.

Conclusions:

• Diabetes mellitus significantly alters HDL structure and function, promoting atherosclerosis.
• Understanding these HDL changes is crucial for managing cardiovascular risk in diabetic patients.
• Targeting HDL dysfunction presents a potential therapeutic avenue for reducing CVD in diabetes.